4th Quarter - Report

ALCON LABORATORIES, INC. for ALCON LABORATORIES INC

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Prescription drug importation and issues concerning anti-counterfeiting and pedigree of prescription drugs, including H.R. 5839, Safeguarding America's Pharmaceutical Act.

Foreign entity interest: Nestle S.A. is a foreign entity that as of December 31, 2008 owned approximately 51% of Alcon, Inc. stock. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.

LobbyistCovered position, as disclosed
BRETTE MCCLELLAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5839 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.